Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Exercise and Nutritional Intervention in Older Adults With Sarcopenia (Spleen-Kidney Deficiency Pattern)

10. november 2026 oppdatert av: Fenghua Qian, Shanghai Yueyang Integrated Medicine Hospital

A Prospective Single-Arm Cohort Study of Exercise and Nutritional Intervention in Older Adults With Sarcopenia (Spleen-Kidney Deficiency Pattern)

This study will enroll older adults with sarcopenia (Spleen-Kidney Deficiency Pattern) who will receive exercise and nutritional interventions. By assessing changes from baseline in DXA-measured appendicular muscle mass and other efficacy outcomes, the study aims to characterize the longitudinal changes in sarcopenia over a 24-week period and provide an external control for a future randomized, double-blind clinical trial of Peiyuan Guben Tongluo Ointment in older adults with sarcopenia (Spleen-Kidney Deficiency Pattern).

Studieoversikt

Studietype

Intervensjonell

Registrering (Antatt)

120

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiekontakt

  • Navn: Xiao ya Zhang, Undergraduate
  • Telefonnummer: +86 13645337890
  • E-post: 2365672026@qq.com

Studiesteder

    • Shanghai Municipality
      • Shanghai, Shanghai Municipality, Kina, 200437
        • Rekruttering
        • Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

60 år til 90 år (Voksen, Eldre voksen)

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

  1. Patients aged ≥ 60 and ≤ 90 years, regardless of sex.
  2. Meet the diagnostic criteria for sarcopenia in older adults according to both Western medicine and traditional Chinese medicine (TCM).
  3. Meet the TCM diagnostic criteria for the Spleen-Kidney Deficiency Pattern.
  4. Be willing to comply with the study intervention protocol, attend scheduled follow-up visits, and provide written informed consent.

Exclusion Criteria:

  1. Patients with severe cerebrovascular diseases resulting in quadriplegia, long-term bedridden status, or complete loss of muscle strength (Grade 0); patients with muscle atrophy caused by various factors; or those unable to perform activities of daily living independently.
  2. Patients with Alzheimer's disease or vascular dementia accompanied by impaired consciousness, aphasia, delirium, inability to communicate or respond appropriately, or disorientation to time, place, or person.
  3. Patients with severe psychiatric disorders or depressive conditions who are receiving relevant pharmacological treatment.
  4. Patients with comorbid conditions that may affect nutritional status, including malignancies, severe infections, gastrointestinal bleeding, hepatic or renal insufficiency, or cardiac insufficiency.
  5. Patients who have received or are currently receiving traditional Chinese medicine treatment within the past month, or who have received medications affecting muscle contraction or relaxation within the past month.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Behandling
  • Tildeling: N/A
  • Intervensjonsmodell: Enkeltgruppeoppdrag
  • Masking: Ingen (Open Label)

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
DXA-measured appendicular skeletal muscle mass
Tidsramme: Baseline, week 12, week 24

Detected by dual-energy X-ray absorptiometry (GE Healthcare, DXA). The skeletal muscle mass index (SMI) is defined as the ratio of DXA-measured skeletal muscle mass to the square of height.

Baseline, week 12, week 24

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Upper limb handgrip strength
Tidsramme: Up to 24 weeks

Use a hand dynamometer to record grip strength data for comparison.

Up to 24 weeks
Handgrip strength
Tidsramme: Baseline, week 12, week 24

Use a hand dynamometer to record grip strength data for comparison.

Baseline, week 12, week 24
Timed Up and Go test (TUG)
Tidsramme: Baseline, week 12, week 24

Subjects shall sit on a chair with a seat height of 46 cm, a straight backrest and armrests (armrest height approximately 65 cm). They are required to stand up with minimal assistance from the armrests. The total time is recorded from leaving the backrest to standing upright, walking 3 meters at their usual walking speed, turning around, walking back, and sitting down fully against the chair back. The average value of three trials is calculated. Elderly individuals who routinely use walking aids may use them during the test.

Baseline, week 12, week 24
Berg Balance Scale (BBS)
Tidsramme: Baseline, week 12, week 24

The scale consists of 14 items in total, including sitting to standing, standing to sitting, standing unsupported, standing with eyes closed, reaching forward with outstretched arms, turning 360 degrees, alternating foot placement on a step, single-leg standing, etc. All items take 10-15 minutes to complete. Each item is scored from a minimum of 0 points to a maximum of 4 points, with a total possible score of 56 points. A higher score indicates better balance function; a score below 40 points suggests an increased risk of falls.

Baseline, week 12, week 24
TCM Syndrome Score
Tidsramme: Baseline, week 12, week 24

In accordance with the scoring criteria specified in the 《Guiding Principles for Clinical Research of New Traditional Chinese Medicine Drugs》, the total score for **Spleen-Kidney Deficiency Syndrome** was calculated.

Baseline, week 12, week 24
Mini Nutritional Assessment (MNA)
Tidsramme: Baseline, week 12, week 24

Nutritional status was evaluated using the Mini Nutritional Assessment (MNA). This scale comprehensively evaluates an individual's nutritional status through a series of questions covering body weight, dietary intake, mobility, mental state and other aspects. The full score of the scale is 30 points. Grading criteria: a total score ≥ 24 indicates good nutritional status; a score between 17 and 24 suggests risk of malnutrition; a total score below 17 confirms definite malnutrition.

Baseline, week 12, week 24
Activities of Daily Living (ADL) Scale
Tidsramme: Baseline. week 12, week 24

The Activities of Daily Living (ADL) scale, developed by American scholars Lawton and Brody in 1969, is a medical assessment tool composed of the Physical Self-Maintenance Scale (PSMS) and the Instrumental Activities of Daily Living (IADL). It is mainly used to evaluate subjects' functional levels in basic living skills such as feeding, dressing and mobility, as well as the ability to use instrumental tools. Constructed from two dimensions including PSMS and IADL, the scale contains a total of 10 assessment items.

Baseline. week 12, week 24

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Etterforskere

  • Hovedetterforsker: Fenghua Qian, Undergraduate, Shanghai Yueyang Integrated Medicine Hospital

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

17. oktober 2026

Primær fullføring (Antatt)

15. april 2027

Studiet fullført (Antatt)

15. oktober 2027

Datoer for studieregistrering

Først innsendt

10. november 2026

Først innsendt som oppfylte QC-kriteriene

10. november 2026

Først lagt ut (Faktiske)

16. november 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

16. november 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

10. november 2026

Sist bekreftet

1. november 2026

Mer informasjon

Begreper knyttet til denne studien

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

NEI

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere